Care of Patients With HIV Infection: Primary Care.
With the advent of antiretroviral therapy and improved access to care, the average life expectancy of patients with HIV infection receiving optimal treatment approaches that of patients in the general population. AIDS-related opportunistic infections and malignancies are no longer the primary issues; instead, traditional age- and lifestyle-related conditions are a growing concern. Patients with HIV infection are at higher risk of cardiovascular disease, diabetes, hypertension, and some non-AIDS-related cancers than patients in the general population. Family physicians need to be knowledgeable about screening for and managing chronic comorbid conditions as this population ages. Health maintenance, including appropriate vaccinations, prophylaxis against opportunistic infections, and routine screening for sexually transmitted infections, remains an important part of care. As HIV infection becomes a chronic condition, emerging strategies in prevention, including preexposure prophylaxis, fall within the scope of practice of the family physician.
Family Health Center of Worcester, 26 Queen St., Worcester, MA 01610.
Philip
P
Bolduc
Family Health Center of Worcester, 26 Queen St., Worcester, MA 01610.
Navid
N
Roder
Family Health Center of Worcester, 26 Queen St., Worcester, MA 01610.
Emily
E
Colgate
University of Massachusetts Medical School, 55 N Lake Ave, Worcester, MA 01655.
Sarah H
SH
Cheeseman
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology / Q000517:prevention & control; D000328:Adult; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D002908:Chronic Disease; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D055088:Early Detection of Cancer; D015658:HIV Infections / Q000453:epidemiology / Q000628:therapy*; D006525:Hepatitis, Viral, Human / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D007252:Influenza Vaccines / Q000627:therapeutic use; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control; D007333:Insulin Resistance; D008297:Male; D008403:Mass Screening; D009369:Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000627:therapeutic use; D011320:Primary Health Care; D012749:Sexually Transmitted Diseases / Q000175:diagnosis* / Q000453:epidemiology; D014761:Viral Hepatitis Vaccines
D007252:Influenza Vaccines; D053918:Papillomavirus Vaccines; D014761:Viral Hepatitis Vaccines